Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 6 Ratios of pre-vaccination HAI antibody titers measured using current season vaccine strain antigens over those using prior season vaccine strain antigens among individuals who participated in respective two consecutive study seasonsa

From: Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older

Vaccine strain

Individual study season

Unadjusted

Adjustedb

IAV H3N2

2015 (n = 49)

0.39 (0.32–0.47) (p < .01)

0.36 (0.36–0.50) (p < .01)

2016 (n = 52)

0.64 (0.50–0.81) (p < .01)

0.56 (0.33–0.94) (p = .03)

IBV

2015 (n = 49)

0.48 (0.41–0.55) (p < .01)

0.41 (0.32–0.51) (p < .01)

2016 (n = 52)

1.77 (1.32–2.37) (p < .01)

0.84 (0.47–1.49) (p = .55)

IAV H1N1

2017 (n = 78)

0.86 (0.79–0.94) (p < .01)

0.86 (0.75–0.99) (p = .04)

  1. aRatios of pre-vaccination HAI titers measured using current study season vaccine strain antigens over those measured using prior season vaccine strain antigens among individuals who participated in the same two consecutive study seasons as the main analysis
  2. bAdjusted for age at the study season, sex, race, and education